Drug intelligence / Profile preview

Fukeyangrong

Development stage: Preclinical
Lead developer: General Hospital of Ningxia Medical University
Administration: Oral

Overview

Fukeyangrong is a Traditional Chinese Medicine (TCM) formulation, primarily administered in capsule form, used for the treatment of gynecological disorders such as ovarian reserve dysfunction and infertility. It is specifically indicated for patients exhibiting the TCM pattern of kidney deficiency and blood stasis. The formulation is designed to nourish blood, tonify the kidneys, and improve blood circulation to enhance ovarian function and reproductive outcomes. It has been evaluated in clinical studies by the General Hospital of Ningxia Medical University to investigate its efficacy in reducing infertility associated with diminished ovarian reserve.

Brand names: Fukeyangrong capsule
Other names: Fukeyangyan CapsuleFuke Yangrong

Beyond the preview

Go deeper on Fukeyangrong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fukeyangrong.

Explore the full profile